Ignite Creation Date:
2025-12-24 @ 10:36 PM
Ignite Modification Date:
2025-12-28 @ 11:18 PM
Study NCT ID:
NCT01450735
Status:
TERMINATED
Last Update Posted:
2013-01-15
First Post:
2011-10-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of the MANOS Carpal Tunnel Release System in Patients With Carpal Tunnel Syndrome
Sponsor:
Thayer Intellectual Property, Inc.
Organization:
Study Overview
Official Title:
None
Status:
TERMINATED
Status Verified Date:
2013-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Enrollment did not reach our intended sample size due to availability of CTR with MANOS outside of the study.
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The MANOS device is a carpal tunnel blade used to perform carpal tunnel release (CTR). CTR is indicated for the treatment of Carpal Tunnel Syndrome when conservative therapy fails. This study is being conducted to evaluate the safety and effectiveness of CTR with the MANOS device.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: